期刊文献+

Inhibitory effect and mechanism of acarbose combined with gymnemic acid on maltose absorption in rat intestine 被引量:2

Inhibitory effect and mechanism of acarbose combined with gymnemic acid on maltose absorption in rat intestine
下载PDF
导出
摘要 AIM: To compare the combinative and individual effect of acarbose and gymnemic acid (GA) on maltose absorption and hydrolysis in small intestine to determine whether nutrient control in diabetic care can be improved by combination of them. METHODS: The absorption and hydrolysis of maltose were studied by cyclic perfusion of intestinal loops in situ and motility of the intestine was recorded with the intestinal ring in vitro using Wistar rats. RESULTS: The total inhibitory rate of maltose absorption was improved by the combination of GA (0.1g/L-1.0 g/L) and acarbose (0.1 mmol/L-2.0 mmol/L) throughout their effective duration (P 【0.05, U test of Mann-Whitney), although the improvement only could be seen at a low dosage during the first hour. With the combination, inhibitory duration of acarbose on maltose absorption was prolonged to 3h and the inhibitory effect onset of GA was fastened to 15 min. GA suppressed the intestinal mobility with a good correlation (r = 0.98) to the inhibitory effect of GA on maltose absorption and the inhibitory effect of 2 mmol/L (high dose) acarbose on maltose hydrolysis was dual modulated by 1g/L GA in vivo indicating that the combined effects involved the functional alteration of intestinal barriers. CONCLUSION: There are augmented effects of acarbose and GA,which involve pre-cellular and paracellular barriers. Diabetic care can be improved by employing the combination. AIM To compare the combinative andindividual effect of acarbose and gymnemic acid(GA) on maltose absorption and hydrolysis insmall intestine to determine whether nutrientcontrol in diabetic care can be improved bycombination of them.METHODS The absorption and hydrolysis ofmaltose were studied by cyclic perfusion ofintestinal loops in situ and motility of theintestine was recorded with the intestinal ring invitro using Wistar rats.RESULTS The total inhibitory rate of maltoseabsorption was improved by the combination ofGA (0.1 g/L 1.0 g/L) and acarbose(0.1 mmol/L 2.0 mmol/L) throughout theireffective duration (P<0.05, U test of Mann-Whitney), although the improvement only couldbe seen at a Iow dosage during the first hour.With the combination, inhibitory duration of acarbose on maltose absorption was prolonged to 3 h and the inhibitory effect onset of GA was fastened to 15min. GA suppressed the intestinal mobility with a good correlation (r-0.98) to the inhibitory effect of GA on maltose absorption and the inhibitory effect of 2mmol/L (high dose) acarbose on maltose hydrolysis was dual modulated by 1 g/L GA in vivo indicating that the combined effects involved the functional alteration of intestinal barriers.CONCLUSION There are augmented effects of acarbose and GA, which involve pre-cellular and paracellular barriers. Diabetic care can be improved by employing the combination.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第1期9-15,共7页 世界胃肠病学杂志(英文版)
基金 Supported by Grant for Promotion of Science from Tottori Bioscience Foundation(1997-1998) Japan and Japanese Government(Ministry of Education,Science and Culture of Japan,MONBUSHO)scholarship No.933241(1994-1999) Japan in part.Dr.Luo was supported by the scholarships.
  • 相关文献

参考文献15

  • 1H. Kentrup,H. Bongers,M. Spengler,G. Kusenbach,H. Skopnik.Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance[J].European Journal of Pediatrics.1999(6)
  • 2Burkhard Lorenz Herrmann,Helmut Schatz,Andreas Pfeiffer.Kontinuierliche Blutglucosemessungen: Der Akuteffekt von Acarbose auf die Blutglucoseschwankungen[J].Medizinische Klinik.1998(11)
  • 3A.B.R. Thomson,G. Wild.Adaptation of Intestinal Nutrient Transport in Health and Disease (Part I)[J].Digestive Diseases and Sciences.1997(3)
  • 4A.B.R. Thomson,G. Wild.Adaptation of Intestinal Nutrient Transport in Health and Disease (Part II)[J].Digestive Diseases and Sciences.1997(3)
  • 5Katsuaki Arai,Rieko Ishima,Soichi Morikawa,Akiko Miyasaka,Toshiaki Imoto,Shoko Yoshimura,Saburo Aimoto,Kazuyuki Akasaka.Three-dimensional structure of gurmarin, a sweet taste-suppressing polypeptide[J].Journal of Biomolecular NMR.1995(3)
  • 6Junger C,Rathmann W,Giani G.Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting[].Deutsche Medizinische Wochenschrift.2000
  • 7Scheen AJ.Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials[].Diabetes and Metabolism.1998
  • 8Baskaran K,Kizar Ahamath B,Radha Shanmugasundaram K,Shanmugasundaram ER.Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitua patients[].Journal of Ethnopharmacology.1990
  • 9Imoto T,Yamamoto FM,Miyasaka A,Hatano H.High-performance liquid chromatography-atmospheric pressure ionization mass spectrometry of gymnemic acids[].Journal of Chromatography.1991
  • 10Fuahiki T,Kojima A,Imoto T,Inoue K,Sugimoto E.An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats[].The Journal of Nutrition.1992

同被引文献13

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部